198 related articles for article (PubMed ID: 23766486)
1. Clinical features of patients with infections caused by Candida guilliermondii and Candida fermentati and antifungal susceptibility of the isolates at a medical centre in Taiwan, 2001-10.
Chen CY; Huang SY; Tang JL; Tsay W; Yao M; Ko BS; Chou WC; Tien HF; Hsueh PR
J Antimicrob Chemother; 2013 Nov; 68(11):2632-5. PubMed ID: 23766486
[TBL] [Abstract][Full Text] [Related]
2. Clinical manifestations of candidemia caused by uncommon Candida species and antifungal susceptibility of the isolates in a regional hospital in Taiwan, 2007-2014.
Liu WL; Lai CC; Li MC; Wu CJ; Ko WC; Hung YL; Tang HJ; Hsueh PR
J Microbiol Immunol Infect; 2019 Aug; 52(4):612-619. PubMed ID: 28886952
[TBL] [Abstract][Full Text] [Related]
3. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F
Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
[TBL] [Abstract][Full Text] [Related]
4. Clinical features, antifungal susceptibility, and outcome of Candida guilliermondii fungemia: An experience in a tertiary hospital in mid-Taiwan.
Tseng TY; Chen TC; Ho CM; Lin PC; Chou CH; Tsai CT; Wang JH; Chi CY; Ho MW
J Microbiol Immunol Infect; 2018 Aug; 51(4):552-558. PubMed ID: 28625801
[TBL] [Abstract][Full Text] [Related]
5. Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran.
Razzaghi-Abyaneh M; Sadeghi G; Zeinali E; Alirezaee M; Shams-Ghahfarokhi M; Amani A; Mirahmadi R; Tolouei R
J Mycol Med; 2014 Jun; 24(2):e43-50. PubMed ID: 24767256
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
Pfaller MA; Chaturvedi V; Diekema DJ; Ghannoum MA; Holliday NM; Killian SB; Knapp CC; Messer SA; Miskou A; Ramani R
Diagn Microbiol Infect Dis; 2012 Aug; 73(4):365-8. PubMed ID: 22726528
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Microbiological Characteristics of Candida guilliermondii and Candida fermentati.
Hirayama T; Miyazaki T; Yamagishi Y; Mikamo H; Ueda T; Nakajima K; Takesue Y; Higashi Y; Yamamoto Y; Kimura M; Araoka H; Taniguchi S; Fukuda Y; Matsuo Y; Furutani A; Yamashita K; Takazono T; Saijo T; Shimamura S; Yamamoto K; Imamura Y; Izumikawa K; Yanagihara K; Kohno S; Mukae H
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581115
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010.
Chen CY; Huang SY; Tsay W; Yao M; Tang JL; Ko BS; Chou WC; Tien HF; Hsueh PR
Int J Antimicrob Agents; 2012 Dec; 40(6):533-8. PubMed ID: 23006521
[TBL] [Abstract][Full Text] [Related]
9. Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric method.
Espinel-Ingroff A; Alvarez-Fernandez M; Cantón E; Carver PL; Chen SC; Eschenauer G; Getsinger DL; Gonzalez GM; Govender NP; Grancini A; Hanson KE; Kidd SE; Klinker K; Kubin CJ; Kus JV; Lockhart SR; Meletiadis J; Morris AJ; Pelaez T; Quindós G; Rodriguez-Iglesias M; Sánchez-Reus F; Shoham S; Wengenack NL; Borrell Solé N; Echeverria J; Esperalba J; Gómez-G de la Pedrosa E; García García I; Linares MJ; Marco F; Merino P; Pemán J; Pérez Del Molino L; Roselló Mayans E; Rubio Calvo C; Ruiz Pérez de Pipaon M; Yagüe G; Garcia-Effron G; Guinea J; Perlin DS; Sanguinetti M; Shields R; Turnidge J
Antimicrob Agents Chemother; 2015 Nov; 59(11):6725-32. PubMed ID: 26282428
[TBL] [Abstract][Full Text] [Related]
10. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features.
Kim MN; Shin JH; Sung H; Lee K; Kim EC; Ryoo N; Lee JS; Jung SI; Park KH; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
Clin Infect Dis; 2009 Mar; 48(6):e57-61. PubMed ID: 19193113
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G;
J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683
[TBL] [Abstract][Full Text] [Related]
12. Antifungal susceptibility and distribution of Candida spp. isolates from the University Hospital in the municipality of Dourados, State of Mato Grosso do Sul, Brazil.
Almeida AA; Mesquita CS; Svidzinski TI; Oliveira KM
Rev Soc Bras Med Trop; 2013; 46(3):335-9. PubMed ID: 23856873
[TBL] [Abstract][Full Text] [Related]
13. Identification and Susceptibility Profile of Candida fermentati from a worldwide collection of Candida guilliermondii clinical isolates.
Lockhart SR; Messer SA; Pfaller MA; Diekema DJ
J Clin Microbiol; 2009 Jan; 47(1):242-4. PubMed ID: 19036938
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
[TBL] [Abstract][Full Text] [Related]
15. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.
Schmalreck AF; Willinger B; Haase G; Blum G; Lass-Flörl C; Fegeler W; Becker K;
Mycoses; 2012 May; 55(3):e124-37. PubMed ID: 22233267
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR].
Gültekin B; Eyigör M; Tiryaki Y; Kırdar S; Aydın N
Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074
[TBL] [Abstract][Full Text] [Related]
17. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
18. Influence of serum on in vitro susceptibility testing of echinocandins for Candida parapsilosis and Candida guilliermondii.
Saribas Z; Yurdakul P; Cetin-Hazirolan G; Arikan-Akdagli S
Mycoses; 2012 Mar; 55(2):156-60. PubMed ID: 21668525
[TBL] [Abstract][Full Text] [Related]
19. Identification and Antifungal Susceptibility Profile of Candida guilliermondii and Candida fermentati from a Multicenter Study in China.
Cheng JW; Yu SY; Xiao M; Wang H; Kudinha T; Kong F; Xu YC
J Clin Microbiol; 2016 Aug; 54(8):2187-9. PubMed ID: 27252461
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology and antifungal susceptibility of Candida parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis in Taiwan.
Chen YC; Lin YH; Chen KW; Lii J; Teng HJ; Li SY
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):284-92. PubMed ID: 20851551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
